James O’Brien, a biotech and financial executive, has been appointed chief financial officer of Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company located in Finland. Mr O’Brien has extensive experience in the US capital markets having completed an initial public offering on Nasdaq in 2021 for Cognition Therapeutics Inc, a US neuroscience company. Prior to this he served as executive vice president of finance at Enzo Biochem Inc, a developer of molecular diagnostics.
Mr O’Brien is a certified public accountant with a bachelor of accountancy from George Washington University and a master of business administration from Fordham University, both in the US.
Faron Pharmaceuticals announced the appointment on 29 March 2023.
Copyright 2023 Evernow Publishing Ltd